CARL ZEISS MEDITEC AG
Ownership & governance
Executives 5Directors 10Avg age 53Avg tenure 5.8y
AP
Andreas Pecher
Chief Executive Officer
Age 55Since 2025-12-31Profile →
+14
Executives5
Board of directors10
TG
Tania von der Goltz→
Director/Board Member
Age 58Since 2018-04-09
KL
Karl Lamprecht→
Chairman
Age 62Since 2021-05-26
IP
Isabel de Paoli→
Director/Board Member
Age 52Since 2020-06-24
RD
Rene Denner→
Director/Board Member
Age 46Since 2018-12-31
JM
Jeffrey Marx→
Director/Board Member
Age 40Since 2020-03-05
PK
Peter Kameritsch→
Director/Board Member
Age 57Since 2021-05-26
TR
Torsten Reitze→
Director/Board Member
Age 49Since 2021-05-26
BK
Brigitte Koblizek→
Director/Board Member
Age 60Since 2022-03-29
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Carl-Zeiss-Stiftung | 59.14 % | 52,893,270 |
| Capital Research & Management Co. (World Investors) | 3.536 % | 3,162,336 |
| CARL ZEISS MEDITEC AG | 2.129 % | 1,904,491 |
| Lazard Asset Management Pacific Co. | 0.6075 % | 543,324 |
| Zenito Oy | 0.2236 % | 200,000 |
Catalog · 2026-07-09
Registry officers15
| Name | Role | Since | Shares |
|---|---|---|---|
| Andreas Pecher | Chief Executive Officer | 2025-12-31 | - |
| Justus Felix Wehmer | Director of Finance/CFO | 2018-09-30 | - |
| Karl Lamprecht | Chairman | 2021-05-26 | - |
| Stefanie Spanagel | Chief Operating Officer | — | - |
| Brigitte Koblizek | Director/Board Member | 2022-03-29 | - |
| Falk Bindheim | Director/Board Member | 2023-03-21 | - |
| Heike Madan | Director/Board Member | 2023-03-21 | - |
| Isabel de Paoli | Director/Board Member | 2020-06-24 | - |
Registry · as of 2026-07-09
Group companies
| Name | Category |
|---|---|
| Carl Zeiss Meditec Co., Ltd. | Medical Distributors |
| HYALTECH Ltd. | Biotechnology |
| Carl Zeiss Meditec, Inc. | Medical Specialties |
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus underperformMean target 26.89Range 18.1–35Analysts 15
18.1Mean 26.8935
- Hold 9
- Sell 5
- Strong sell 1
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.